Endocan Corp. (ENDO)
OTOTC · Common · CUSIP 98371P109
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for ENDO and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
98371P109
Market Cap
Micro Cap · $2 Million
Previous Symbol
XCHC_ (changed 11/6/2013)
Previous Name
X-Change Corp. (The)
Business: Endocan is the next stage of innovative cannabinoid-based solutions, with a focus on the health needs of people today. Globally, the diagnoses of critical ailments such as HIV/AIDS, cancer, autoimmune disease, high blood pressure, dementia, and more are arising. Despite scientific advances, they are facing a situation in which millions of people continue to be affected by life-threatening conditions with no truly effective means of treating them. The world needs smart science and research, strong leadership, and new products to respond to ever growing medical need.

Company Contact

CEO
Robert J. Kane
CFO
Robert J. Kane
Headquarters
2910 North Powers Boulevard, Suite 125, Colorado Springs, CO 80922
Phone
866-326-5595 · Toll-Free 866-326-5595
Investor Relations
561-420-4824 · robert.kane@endocan.com
General Email
info@endocan.com
SEC EDGAR Filings
View filings »